參考文獻/References:
[1] JIA W, WENG J, ZHU D, et al.Standards of medical care for type 2 diabetes in China 2019[J].Diabetes Metab Res Rev, 2019, 35(6): e3158.
[2] VIIGIMAA M, SACHINIDIS A, TOUMPOURLEKA M, et al.Macrovascular complications of type 2 diabetes mellitus[J].Curr Vasc Pharmacol, 2020, 18(2): 110-116.
[3] ARNETT D K, BLUMENTHAL R S, ALBERT M A, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].Circulation, 2019, 140(11): e563-e595.
[4] STANDL E, JANKA H U.High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes[J].Horm Metab Res Suppl, 1985, 15: 46-51.
[5] GEDEBJERG A, BJERRE M, KJAERGAARD A D, et al.CRP, C-Peptide, and risk of first-time cardiovascular events and mortality in early type 2 diabetes: A Danish cohort study[J].Diabetes Care, 2023, 46(5): 1037-1045.
[6] JAHROMI M K, AHMADIRAD H, JAMSHIDI S, et al.The association of serum C-peptide with the risk of cardiovascular events: a meta-analysis and systematic review[J].Diabetol Metab Syndr, 2023, 15(1): 168.
[7] WAHAB M A, ALHABIBI A M, SAKR A K, et al.The correlation Between C-peptide and severity of peripheral atherosclerosis in type 2 diabetes mellitus[J].Diabetes Metab Syndr Obes, 2023, 16: 2617-2625.
[8] WANG Y, WAN H, CHEN Y, et al.Association of C-peptide with diabetic vascular complications in type 2 diabetes[J].Diabetes Metab, 2020, 46(1): 33-40.
[9] TOFFOLO G, DE GRANDI F, COBELLI C.Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data.Knowledge of the kinetics avoids errors in modeling the secretion[J].Diabetes, 1995, 44(7): 845-854.
[10] TOPRAK K, KAPLANGORAY M, PALICE A.The impact of C-peptide and diabetes mellitus on coronary ectasia and effect of coronary ectasia and C-peptide on long-term outcomes: A retrospective cohort study[J].Int J Clin Pract, 2022, 2022: 7910566.
[11] QIN J, SUN R, DING D.Effects of serum C-peptide level on blood lipid and cardiovascular and cerebrovascular injury in patients with type 2 diabetes mellitus: A Meta-analysis[J].Contrast Media Mol Imaging, 2022, 2022: 6314435.
[12] YAN S T, SUN J, GU Z Y, et al.The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study[J].Cardiovasc Diabetol, 2022, 21(1): 201.
[13] KAUTZKY-WILLER A, LEUTNER M, HARREITER J.Sex differences in type 2 diabetes[J].Diabetologia, 2023, 66(6): 986-1002.
[14] LIU J, JIN X, LIU W, et al.The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis[J].Front Cardiovasc Med, 2023, 10: 1131251.
[15] SHI S, NI L, TIAN Y, et al.Association of obesity indices with diabetic kidney disease and diabetic retinopathy in type 2 diabetes: A real-world study[J].J Diabetes Res, 2023, 2023: 3819830.
[16] AUSK K J, BOYKO E J, IOANNOU G N.Insulin resistance predicts mortality in nondiabetic individuals in the U.S[J].Diabetes Care, 2010, 33(6): 1179-1185.
[17] PATEL N, TAVEIRA T H, CHOUDHARY G, et al.Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults[J].J Am Heart Assoc, 2012, 1(6): e3152.
[18] CHEN J, HUANG Y, LIU C, et al.The role of C-peptide in diabetes and its complications: an updated review[J].Front Endocrinol(Lausanne), 2023, 14: 1256093.
[19] LEE S K, LEE J O, KIM J H, et al.C-peptide stimulates nitrites generation via the calcium-JAK2/STAT1 pathway in murine macrophage Raw264.7 cells[J].Life Sci, 2010, 86(23-24): 863-868.
[20] MARX N, WALCHER D, RAICHLE C, et al.C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro[J].Arterioscler Thromb Vasc Biol, 2004, 24(3): 540-545.